awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37778400-CB526B33-2E3A-49DE-9220-FB2467F1AA80
Q37778400-CB526B33-2E3A-49DE-9220-FB2467F1AA80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37778400-CB526B33-2E3A-49DE-9220-FB2467F1AA80
Emerging drugs for high-grade osteosarcoma.
P2860
Q37778400-CB526B33-2E3A-49DE-9220-FB2467F1AA80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37778400-CB526B33-2E3A-49DE-9220-FB2467F1AA80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f8ad42de0934545ff8991b3d2d7c3f629ba7460
P2860
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.